ClinicalTrials.gg
Sign In

Death clinical trials

The registry lists 456 studies for Death across more than 10 countries. 86 are recruiting or about to start. 209 of them are mainly about Death (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 12 narrower conditions too, such as Death, Sudden, Cardiac: 1,391 studies, 292 open.

Get an email when these change. Save the Death studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
243
Status unknown
68
Recruiting
58
Active, not recruiting
35
Not yet recruiting
22
Terminated
14

Phase

Phase 3
17
Phase 4
12
Phase 2
11
Phase 1
6
Early Phase 1
2

Where

United States
118
France
51
Canada
43
China
29
Germany
22
Italy
17

Who runs them

Chang Gung Memorial Hospital (8) · Stanford University (8) · Assistance Publique - Hôpitaux de Paris (7) · Ottawa Hospital Research Institute (7) · University Hospital, Strasbourg, France (6) · National Cancer Institute (NCI) (5) · Huazhong University of Science and Technology (5) · University of Pittsburgh (5)

What is being tested here

Drugs under test in Death studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexmedetomidine102
Dapagliflozin011
Retatrutide011
Azithromycin001
Cholecalciferol001
Dextromethorphan001
Sodium Oxybate001
Oxybate001
Rosuvastatin011
Vitamin D011

Coming up

5phase 3 studies under way
33studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 58 Death studies recruiting now, 43 (74%) set no upper age limit and 8 (14%) stop at 75 or younger. 11 (19%) take children under 18. 3 (5%) are for women only and 0 (0%) for men only; 14 (24%) take healthy volunteers.

Recruiting studies that take each age, of 58
AgeWomenMen
108 (14%)7 (12%)
1843 (74%)41 (71%)
3047 (81%)45 (78%)
4046 (79%)44 (76%)
5045 (78%)44 (76%)
6548 (83%)46 (79%)
7549 (84%)47 (81%)
8547 (81%)45 (78%)

Across all 456 studies, recruiting or not: 17% stop at 75 or younger and 13% at 65; 21% take children; 3% are for women only and 1% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Death studies take

Of 109 interventional studies with no phase under Death, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase24 mo14–48 · 109 studies—24 mo14–48 · 105 studies
Observational60 mo23–245 · 87 studies—60 mo23–245 · 84 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 456. Browse all 456 → or search them.